|
FEM1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.456010E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.496210E-03 |
| Normal-vs-Stage2 |
4.969400E-01 |
| Normal-vs-Stage3 |
5.783700E-04 |
| Normal-vs-Stage4 |
1.907960E-02 |
| Stage1-vs-Stage2 |
3.366400E-02 |
| Stage1-vs-Stage3 |
3.427000E-01 |
| Stage1-vs-Stage4 |
8.975000E-01 |
| Stage2-vs-Stage3 |
1.234200E-02 |
| Stage2-vs-Stage4 |
1.200830E-01 |
| Stage3-vs-Stage4 |
4.364800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.023900E-04 |
| Normal-vs-AfricanAmerican |
2.770000E-01 |
| Normal-vs-Asian |
7.832100E-02 |
| Caucasian-vs-AfricanAmerican |
2.333400E-01 |
| Caucasian-vs-Asian |
2.331200E-01 |
| AfricanAmerican-vs-Asian |
7.819400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.715300E-03 |
| Normal-vs-Female |
1.798050E-03 |
| Male-vs-Female |
9.194400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.833500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.820400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.289600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.037800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.427000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.961000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.720420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.834200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.111200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.645800E-02 |
| Classical-VS-Follicular |
5.068000E-02 |
| Classical-VS-Other |
2.977800E-01 |
| Classical-VS-Normal |
1.860330E-02 |
| Tall-VS-Follicular |
3.524200E-01 |
| Tall-VS-Other |
9.219800E-01 |
| Tall-VS-Normal |
3.410400E-04 |
| Follicular-VS-Other |
7.334600E-01 |
| Follicular-VS-Normal |
1.877720E-03 |
| Other-VS-Normal |
7.851800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.499900E-03 |
| Normal-vs-N1 |
7.72900000000076E-05 |
| N0-vs-N1 |
1.109870E-02 |
|
|
